文献
J-GLOBAL ID:201702261961374427
整理番号:17A1818391
難治性転移性腎細胞癌患者に対するTRC105を用いたベバシズマブ単独または併用【Powered by NICT】
Bevacizumab alone or in combination with TRC105 for patients with refractory metastatic renal cell cancer
著者 (11件):
Dorff Tanya B.
(University of Southern California Keck School of Medicine, Norris Comprehensive Cancer Center, Los Angeles, California)
,
Longmate Jeff A.
(Department of Biostatistics, City of Hope, Duarte, California)
,
Pal Sumanta K.
(Department of Medical Oncology and Experimental Therapeutics, City of Hope, Duarte, California)
,
Stadler Walter M.
(Hematology/Oncology Section, University of Chicago, Chicago, Illinois)
,
Fishman Mayer N.
(Department of Genitourinary Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida)
,
Vaishampayan Ulka N.
(Department of Hematology and Oncology, Karmanos Cancer Center, Detroit, Michigan)
,
Rao Amol
(University of Southern California Keck School of Medicine, Norris Comprehensive Cancer Center, Los Angeles, California)
,
Pinksi Jacek K.
(University of Southern California Keck School of Medicine, Norris Comprehensive Cancer Center, Los Angeles, California)
,
Hu James S.
(University of Southern California Keck School of Medicine, Norris Comprehensive Cancer Center, Los Angeles, California)
,
Quinn David I.
(Department of Medical Oncology, University of Southern California Keck School of Medicine, Norris Comprehensive Cancer Center, Los Angeles, California)
,
Lara Primo N. Jr
(University of California Davis Comprehensive Cancer Center, Sacramento, California)
資料名:
Cancer (Hoboken, N.J.)
(Cancer (Hoboken, N.J.))
巻:
123
号:
23
ページ:
4566-4573
発行年:
2017年
JST資料番号:
D0781B
ISSN:
0008-543X
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
アメリカ合衆国 (USA)
言語:
英語 (EN)